GL1X · GenesisL1 explorer

Research workbench

Baff in complex with belimumab

Analyse Baff in complex with belimumab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Y9J
Type
protein
Length
572 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Belibumab light chain; Belimumab heavy chain; Tumor necrosis factor ligand superfamily…
UniProt
Q9Y275
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LBelibumab light chainprotein2109% helix, 50% strand—
HBelimumab heavy chainprotein2187% helix, 48% strand—
ATumor necrosis factor ligand superfamily member 13Bprotein1440% helix, 56% strandQ9Y275

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11230.760.9530empty
2900.640.9025empty
34690.570.7355empty
41000.410.7717empty
5640.340.7718empty

Interfaces

3 interfaces between chains.

  • L–H · 1622 Ų buried · 10 hydrogen bonds · protein-protein
  • H–A · 560 Ų buried · 10 hydrogen bonds · protein-protein
  • L–A · 439 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5Y9J · BAFF in complex with belimumab · the same entry in another collection · chain L against L, TM-score 1.00
  • Q9Y275 · AlphaFold monomer V2.0 prediction for tumor necrosis factor ligand superfamily member 13B… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.